Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD.

Journal of clinical lipidology - 1 Jan 2000

Vilar-Gomez Eduardo, Gawrieh Samer, Liang Tiebing, McIntyre Adam D, Hegele Robert A, Chalasani Naga

Abstract excerpt

BACKGROUND: The clinical significance of rare mutations in LDL metabolism genes on nonalcoholic fatty liver disease (NAFLD) severity is not well understood. OBJECTIVE: To examine the significance of mutations in LDL metabolism genes including apolipoprotein B (APOB), proprotein convertase subtilisin kexin 9 (PCSK9) and LDL receptor (LDLR) in patients with NAFLD. METHODS: Patients with biopsy-confirmed NAFLD from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Non-alcoholic Fatty Liver Disease

Share to Proprotein Convertase 9

Share to Proprotein Convertases

Share to Receptors, LDL

Share to Serine Endopeptidases

Source

Open in PubMed Open full text

Identifiers

PMID: 33454241
DOI: 10.1016/j.jacl.2020.12.010
PMCID: PMC8187295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD.PMID 33454241Read ↗

Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.Semantic proximity Read ↗

Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD.Semantic proximity Read ↗

Genetic variants in candidate genes influencing NAFLD progression.Semantic proximity Read ↗

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patientsSemantic proximity Read ↗

Clinical and Genetic Predictors of Non-Alcoholic Steatotic Liver Disease and Fibrosis in Lean Individuals.Semantic proximity Read ↗

Steatotic Liver Disease Predicts Lower Likelihood of LDLR Gene Mutations in Young Korean Patients with Suspected Familial Hypercholesterolemia.Semantic proximity Read ↗

The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.Semantic proximity Read ↗

Genetic predisposition in nonalcoholic fatty liver disease.Semantic proximity Read ↗

Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.Semantic proximity Read ↗

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease.Semantic proximity Read ↗

PCSK7: a Novel Regulator of Apolipoprotein B and a Potential Target Against Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.